⌘K
Loading ticker…
MiMedx Group, Inc · Healthcare · Medical Equipment
As of 2026-06-26, MiMedx Group, Inc (MDXG) has a 3-month relative strength percentile of 39 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 40. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 3.6%, relative volume 4.45×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
39 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
MDXG is held by 6 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $15M notional. Top 3 carry $35M.
Top 6 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $15M |
| IWMiShares Russell 2000 ETF | 0.02% | $12M |
| XBIState Street SPDR S&P Biotech ETF | 0.12% | $9M |
| VXFVanguard Extended Market ETF | 0.01% | $5M |
| IWOiShares Russell 2000 Growth ETF | 0.03% | $4M |
| ITOTiShares Core S&P Total U.S. Stock Market ETF | 0.00% | $589K |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | MDXG Jan avg: -1.65% median: -10.65% win: 25% σ: 28.03% n: 4 2022-04-12 → 2026-05-29 | MDXG Feb avg: 5.50% median: 1.02% win: 50% σ: 13.27% n: 4 2022-04-12 → 2026-05-29 | MDXG Mar avg: -15.89% median: -14.40% win: 0% σ: 10.50% n: 4 2022-04-12 → 2026-05-29 | MDXG Apr avg: -8.98% median: -12.80% win: 20% σ: 12.50% n: 5 2022-04-12 → 2026-05-29 | MDXG May avg: 14.21% median: 9.52% win: 60% σ: 23.41% n: 5 2022-04-12 → 2026-05-29 | MDXG Jun avg: -1.63% median: -4.03% win: 25% σ: 10.23% n: 4 2022-04-12 → 2026-05-29 (current) | MDXG Jul avg: 11.46% median: 12.59% win: 75% σ: 10.55% n: 4 2022-04-12 → 2026-05-29 | MDXG Aug avg: -3.57% median: -4.65% win: 25% σ: 5.56% n: 4 2022-04-12 → 2026-05-29 | MDXG Sep avg: -8.93% median: -7.67% win: 0% σ: 8.58% n: 4 2022-04-12 → 2026-05-29 | MDXG Oct avg: 4.66% median: 6.37% win: 75% σ: 11.08% n: 4 2022-04-12 → 2026-05-29 | MDXG Nov avg: 13.30% median: 14.12% win: 75% σ: 18.77% n: 4 2022-04-12 → 2026-05-29 | MDXG Dec avg: 0.20% median: 1.20% win: 50% σ: 11.45% n: 4 2022-04-12 → 2026-05-29 |